We are live on
!
Find out more
E Fund Management Portfolio holdings
AUM
$4.46B
Turnover
13.19%
This Fund
S&P 500
This Quarter
Est. Return
+29.65%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.58B
AUM Growth
+$264M
(+20%)
Cap. Flow
-$56.9M
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24
Avg Time Held
1.8
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JOYY Inc
JOYY
|
+$3.5M |
| 2 |
Weibo
WB
|
+$2.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.76M |
| 4 |
Hesai Group
HSAI
|
+$1.67M |
| 5 |
Structure Therapeutics
GPCR
|
+$1.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAAR Surgical
STAA
|
+$23.4M |
| 2 |
Yum China
YUMC
|
+$14M |
| 3 |
TSMC
TSM
|
+$8.84M |
| 4 |
Pinduoduo
PDD
|
+$8.79M |
| 5 |
Apple
AAPL
|
+$4.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 50.26% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 8.85% |
| 4 | Real Estate | 5.2% |
| 5 | Healthcare | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
DELISTED
Crinetics Pharmaceuticals
CRNX
| $465K | 0.03% |
13,069
+2,914
| +29% | +$89.4K |
2023 Q3
1 quarter
|
|
177
DELISTED
Apellis Pharmaceuticals
APLS
| $458K | 0.03% |
7,657
-3,341
| -30% | -$169K |
2022 Q1
7 quarters
|
|
178
Ardelyx
ARDX
$798M
| $456K | 0.03% |
73,585
+17,193
| +30% | +$77.1K |
2023 Q1
3 quarters
|
|
179
Abbott
ABT
$181B
| $453K | 0.03% |
4,119
+533
| +15% | +$53.3K |
2021 Q1
11 quarters
|
|
180
Twist Bioscience
TWST
$8.8B
| $453K | 0.03% |
12,283
-5,127
| -29% | -$119K |
2022 Q1
7 quarters
|
|
181
Marvell Technology
MRVL
$205B
| $448K | 0.03% |
7,426
-11,872
| -62% | -$641K |
2021 Q1
11 quarters
|
|
182
Keurig Dr Pepper
KDP
$47.1B
| $446K | 0.03% |
13,394
-1,358
| -9% | -$42.3K |
2021 Q1
11 quarters
|
|
183
Halozyme
HALO
$13.8B
| $444K | 0.03% |
12,023
+149
| +1% | +$5.61K |
2021 Q4
8 quarters
|
|
184
Motorola Solutions
MSI
$76.6B
| $439K | 0.03% |
1,402
-117
| -8% | -$35.4K |
2021 Q1
11 quarters
|
|
185
United Therapeutics
UTHR
$22.9B
| $437K | 0.03% |
1,988
-44
| -2% | -$10.1K |
2022 Q1
7 quarters
|
|
186
Ironwood Pharmaceuticals
IRWD
$578M
| $431K | 0.03% |
37,687
-7,209
| -16% | -$71.3K |
2021 Q1
11 quarters
|
|
187
The Kraft Heinz Company
KHC
$28.1B
| $430K | 0.03% |
11,633
-1,201
| -9% | -$40.8K |
2021 Q1
11 quarters
|
|
188
Old Dominion Freight Line
ODFL
$38.9B
| $429K | 0.03% |
2,118
-226
| -10% | -$44.8K |
2022 Q1
7 quarters
|
|
189
Coca-Cola
KO
$404B
| $426K | 0.03% |
7,236
+1,162
| +19% | +$66K |
2021 Q1
11 quarters
|
|
190
American Electric Power
AEP
$69.2B
| $424K | 0.03% |
5,226
-440
| -8% | -$34.2K |
2021 Q1
11 quarters
|
|
191
Paychex
PAYX
$39.7B
| $423K | 0.03% |
3,548
-355
| -9% | -$42.1K |
2021 Q1
11 quarters
|
|
192
Novavax
NVAX
$1.86B
| $415K | 0.03% |
86,558
+35,581
| +70% | +$218K |
2022 Q1
7 quarters
|
|
193
Chevron
CVX
$441B
| $415K | 0.03% |
2,782
+13
| +0.5% | +$1.97K |
2021 Q1
11 quarters
|
|
194
Viking Therapeutics
VKTX
$3.2B
| $413K | 0.03% |
22,195
-6,582
| -23% | -$86.1K |
2023 Q1
3 quarters
|
|
195
DELISTED
Dynavax Technologies
DVAX
| $406K | 0.03% |
29,016
+4,532
| +19% | +$63K |
2021 Q4
8 quarters
|
|
196
Prothena Corp
PRTA
$429M
| $403K | 0.03% |
11,096
+3,037
| +38% | +$117K |
2022 Q1
7 quarters
|
|
197
Illumina
ILMN
$39.6B
| $403K | 0.03% |
2,973
+608
| +26% | +$70.1K |
2021 Q1
11 quarters
|
|
198
Pfizer
PFE
$169B
| $401K | 0.03% |
13,922
+2,514
| +22% | +$76K |
2021 Q1
11 quarters
|
|
199
Gartner
IT
$13B
| $396K | 0.03% |
877
+8
| +0.9% | +$3.2K |
2021 Q1
11 quarters
|
|
200
Unity
U
$17.8B
| $377K | 0.02% |
+9,211
| New | +$284K |
2023 Q4
0 quarters
|
|
Similar funds
E Fund Management's Q4 2023 Portfolio in Review
As of Q4 2023, E Fund Management held 330 positions worth $1.58B, up 20% from $1.31B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
E Fund Management withdrew a net $56.9M in Q4 2023, closing 24 positions and reducing 155 holdings. Its most notable exit was MINISO, an estimated $2.17M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 45% a quarter earlier, followed by Technology and Communication Services.
Against the trend, E Fund Management opened a new position in Hesai Group worth $1.52M.
- E Fund Management's largest Q4 2023 buy was Hesai Group: 170,914 shares worth $1.52M.
- E Fund Management added most to JOYY Inc in Q4 2023, an estimated $3.5M increase.
- E Fund Management's biggest Q4 2023 reduction was STAAR Surgical, cutting an estimated $23.4M.
- E Fund Management fully exited MINISO in Q4 2023, selling an estimated $2.17M.
- E Fund Management's ten largest holdings make up 70% of its $1.58B portfolio in Q4 2023.
- E Fund Management opened 38 new positions and closed 24 in Q4 2023.
- E Fund Management's portfolio value rose 20% quarter-over-quarter to $1.58B.
Based on E Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.